Lanean...
A novel crosstalk between BRCA1 and poly (ADP-ribose) polymerase 1 in breast cancer
BRCA mutations are the main known hereditary factor for breast cancer. Notably, poly (ADP-ribose) polymerase 1 (PARP1) expression status plays a critical role in breast cancer progression and the clinical development of PARP1 inhibitors to treat BRCA-mutated breast cancer has advanced rapidly. Howev...
Gorde:
| Argitaratua izan da: | Cell Cycle |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4613991/ https://ncbi.nlm.nih.gov/pubmed/25485588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/15384101.2014.956507 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|